Skip to main content
Top
Published in: Journal of General Internal Medicine 1/2019

01-01-2019 | Original Research

Influence of Age, Health, and Function on Cancer Screening in Older Adults with Limited Life Expectancy

Authors: Nancy L. Schoenborn, MD, MHS, Jin Huang, MS, Orla C. Sheehan, MD, PhD, Jennifer L. Wolff, PhD, David L. Roth, PhD, Cynthia M. Boyd, MD, MPH

Published in: Journal of General Internal Medicine | Issue 1/2019

Login to get access

Abstract

Background/Objectives

We examined the relationship between cancer screening and life expectancy predictors, focusing on the influence of age versus health and function, in older adults with limited life expectancy.

Design

Longitudinal cohort study

Setting

National Health and Aging Trends Study (NHATS) with linked Medicare claims.

Participants

Three cohorts of adults 65+ enrolled in fee-for-service Medicare were constructed: women eligible for breast cancer screening (n = 2043); men eligible for prostate cancer screening (n = 1287); men and women eligible for colorectal cancer screening (n = 3759).

Measurements

We assessed 10-year mortality risk using 2011 NHATS data, then used claims data to assess 2-year prostate and breast cancer screening rates and 3-year colorectal cancer screening rates. Among those with limited life expectancy (10-year mortality risk > 50%), we stratified participants at each level of predicted mortality risk and split participants in each risk stratum by the median age. We assembled two sub-groups from these strata that were matched on predicted life expectancy: a “younger sub-group” with relatively poorer health/functional status and an “older sub-group” with relatively better health/functional status. We compared screening rates between sub-groups.

Results

For all three cancer screenings, the younger sub-groups (average ages 73.4–76.1) had higher screening rates than the older sub-groups (average ages 83.6–86.9); screening rates were 42.9% versus 34.2% for prostate cancer screening (p = 0.02), 33.6% versus 20.6% for breast cancer screening (p < 0.001), 13.1% versus 6.7% for colorectal cancer screening in women (p = 0.006), and 20.5% versus 12.1% for colorectal cancer screening in men (p = 0.002).

Conclusion

Among older adults with limited life expectancy, those who are relatively younger with poorer health and functional status are over-screened for cancer at higher rates than those who are older with the same predicted life expectancy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Walter LC, Covinsky KE. Cancer screening in elderly patients: A framework for individualized decision making. JAMA. 2001;285(21):2750–2756.CrossRef Walter LC, Covinsky KE. Cancer screening in elderly patients: A framework for individualized decision making. JAMA. 2001;285(21):2750–2756.CrossRef
2.
go back to reference Lee SJ, Boscardin WJ, Stijacic-Cenzer I, et al. Time lag to benefit after screening for breast and colorectal cancer: Meta-analysis of survival data from the united states, sweden, united kingdom, and denmark. BMJ. 2013;346:e8441.CrossRef Lee SJ, Boscardin WJ, Stijacic-Cenzer I, et al. Time lag to benefit after screening for breast and colorectal cancer: Meta-analysis of survival data from the united states, sweden, united kingdom, and denmark. BMJ. 2013;346:e8441.CrossRef
3.
go back to reference Eckstrom E, Feeny DH, Walter LC, et al. Individualizing cancer screening in older adults: A narrative review and framework for future research. J Gen Intern Med 2013;28(2):292–298.CrossRef Eckstrom E, Feeny DH, Walter LC, et al. Individualizing cancer screening in older adults: A narrative review and framework for future research. J Gen Intern Med 2013;28(2):292–298.CrossRef
4.
go back to reference Walter LC, Schonberg MA. Screening mammography in older women: A review. JAMA 2014;311(13):1336–1347.CrossRef Walter LC, Schonberg MA. Screening mammography in older women: A review. JAMA 2014;311(13):1336–1347.CrossRef
5.
go back to reference Day LW, Kwon A, Inadomi JM, et al. Adverse events in older patients undergoing colonoscopy: A systematic review and meta-analysis. Gastrointest Endosc 2011;74(4):885–896.CrossRef Day LW, Kwon A, Inadomi JM, et al. Adverse events in older patients undergoing colonoscopy: A systematic review and meta-analysis. Gastrointest Endosc 2011;74(4):885–896.CrossRef
6.
go back to reference Kistler CE, Kirby KA, Lee D, et al. Long-term outcomes following positive fecal occult blood test results in older adults: Benefits and burdens. Arch Intern Med. 2011;171(15):1344–1351.CrossRef Kistler CE, Kirby KA, Lee D, et al. Long-term outcomes following positive fecal occult blood test results in older adults: Benefits and burdens. Arch Intern Med. 2011;171(15):1344–1351.CrossRef
7.
go back to reference Day LW, Walter LC, Velayos F. Colorectal cancer screening and surveillance in the elderly patient. Am J Gastroenterol. 2011;106(7):1197–206;quiz 1207.CrossRef Day LW, Walter LC, Velayos F. Colorectal cancer screening and surveillance in the elderly patient. Am J Gastroenterol. 2011;106(7):1197–206;quiz 1207.CrossRef
8.
go back to reference Ilic D, Neuberger MM, Djulbegovic M, et al. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;1:CD004720. Ilic D, Neuberger MM, Djulbegovic M, et al. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;1:CD004720.
9.
go back to reference U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–37.CrossRef U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–37.CrossRef
10.
go back to reference U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716–26.CrossRef U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716–26.CrossRef
11.
go back to reference Moyer VA, U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2012;157(2):120–134.CrossRef Moyer VA, U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2012;157(2):120–134.CrossRef
12.
go back to reference U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(3):185–91.CrossRef U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(3):185–91.CrossRef
13.
go back to reference Oeffinger KC, Fontham ET, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599–614.CrossRef Oeffinger KC, Fontham ET, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599–614.CrossRef
14.
go back to reference Reuben DB. Medical care for the final years of life: “when you’re 83, it’s not going to be 20 years”. JAMA. 2009;302(24):2686–2694.CrossRef Reuben DB. Medical care for the final years of life: “when you’re 83, it’s not going to be 20 years”. JAMA. 2009;302(24):2686–2694.CrossRef
15.
go back to reference Qaseem A, Barry MJ, Denberg TD, et al, Clinical Guidelines Committee of the American College of Physicians. Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2013;158(10):761–769CrossRef Qaseem A, Barry MJ, Denberg TD, et al, Clinical Guidelines Committee of the American College of Physicians. Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2013;158(10):761–769CrossRef
16.
go back to reference Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA guideline. J Urol 2003;190(2):419–426.CrossRef Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA guideline. J Urol 2003;190(2):419–426.CrossRef
18.
go back to reference Qaseem A, Denberg TD, Hopkins RH, et al. Screening for Colorectal Cancer: A Guidance Statement From the American College of Physicians. Ann Intern Med. 2012;156(5):378–86.CrossRef Qaseem A, Denberg TD, Hopkins RH, et al. Screening for Colorectal Cancer: A Guidance Statement From the American College of Physicians. Ann Intern Med. 2012;156(5):378–86.CrossRef
19.
go back to reference Royce TJ, Hendrix LH, Stokes WA, et al. Cancer screening rates in individuals with different life expectancies. JAMA Intern Med. 2014;174(10):1558–65.CrossRef Royce TJ, Hendrix LH, Stokes WA, et al. Cancer screening rates in individuals with different life expectancies. JAMA Intern Med. 2014;174(10):1558–65.CrossRef
20.
go back to reference Schonberg MA, Breslau ES, Hamel MB, et al. Colon cancer screening in U.S. adults aged 65 and older according to life expectancy and age. J Am Geriatr Soc 2015;63(4):750–756.CrossRef Schonberg MA, Breslau ES, Hamel MB, et al. Colon cancer screening in U.S. adults aged 65 and older according to life expectancy and age. J Am Geriatr Soc 2015;63(4):750–756.CrossRef
21.
go back to reference Powell AA, Saini SD, Breitenstein MK, et al. Rates and correlates of potentially inappropriate colorectal cancer screening in the veterans health administration. J Gen Intern Med. 2015;30(6):732–741.CrossRef Powell AA, Saini SD, Breitenstein MK, et al. Rates and correlates of potentially inappropriate colorectal cancer screening in the veterans health administration. J Gen Intern Med. 2015;30(6):732–741.CrossRef
22.
go back to reference Drazer MW, Prasad SM, Huo D, et al. National trends in prostate cancer screening among older american men with limited 9-year life expectancies: Evidence of an increased need for shared decision making. Cancer. 2014;120(10):1491–1498.CrossRef Drazer MW, Prasad SM, Huo D, et al. National trends in prostate cancer screening among older american men with limited 9-year life expectancies: Evidence of an increased need for shared decision making. Cancer. 2014;120(10):1491–1498.CrossRef
23.
go back to reference So C, Kirby KA, Mehta K, et al. Medical center characteristics associated with PSA screening in elderly veterans with limited life expectancy. J Gen Intern Med. 2012;27(6):653–660.CrossRef So C, Kirby KA, Mehta K, et al. Medical center characteristics associated with PSA screening in elderly veterans with limited life expectancy. J Gen Intern Med. 2012;27(6):653–660.CrossRef
24.
go back to reference Cruz M, Covinsky K, Widera EW, et al. Predicting 10-year mortality for older adults. JAMA. 2013;309(9):874–876.CrossRef Cruz M, Covinsky K, Widera EW, et al. Predicting 10-year mortality for older adults. JAMA. 2013;309(9):874–876.CrossRef
25.
go back to reference Schonberg MA, Davis RB, McCarthy EP, et al. External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older. J Am Geriatr Soc. 2011;59(8):1444–1451CrossRef Schonberg MA, Davis RB, McCarthy EP, et al. External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older. J Am Geriatr Soc. 2011;59(8):1444–1451CrossRef
26.
go back to reference Schoenborn NL, Bowman TL, Cayea D, et al. Primary care practitioners’ views on incorporating long-term prognosis in the care of older adults. JAMA Intern Med. 2016;176(5):671–8CrossRef Schoenborn NL, Bowman TL, Cayea D, et al. Primary care practitioners’ views on incorporating long-term prognosis in the care of older adults. JAMA Intern Med. 2016;176(5):671–8CrossRef
27.
go back to reference Koya DL, Chen JG, Smith TG, Moran WP. Screening mammography use in Medicare beneficiaries reflects 4-year mortality risk. Am J Med. 2011;124(4):369.e1–8.CrossRef Koya DL, Chen JG, Smith TG, Moran WP. Screening mammography use in Medicare beneficiaries reflects 4-year mortality risk. Am J Med. 2011;124(4):369.e1–8.CrossRef
28.
go back to reference Williams BA, Lindquist K, Sudore RL, Covinsky KE, Walter LC. Screening mammography in older women. Effect of wealth and prognosis. Arch Intern Med. 2008;168(5):514–20.CrossRef Williams BA, Lindquist K, Sudore RL, Covinsky KE, Walter LC. Screening mammography in older women. Effect of wealth and prognosis. Arch Intern Med. 2008;168(5):514–20.CrossRef
29.
go back to reference Schonberg MA, Breslau ES, McCarthy EP. Targeting of mammography screening according to life expectancy in women aged 75 and older. J Am Geriatr Soc. 2013;61(3): 388–95.CrossRef Schonberg MA, Breslau ES, McCarthy EP. Targeting of mammography screening according to life expectancy in women aged 75 and older. J Am Geriatr Soc. 2013;61(3): 388–95.CrossRef
31.
go back to reference Walter LC, Bertenthal D, Lindquist K, et al. PSA screening among elderly men with limited life expectancies. JAMA. 2006;296(19):2336–42.CrossRef Walter LC, Bertenthal D, Lindquist K, et al. PSA screening among elderly men with limited life expectancies. JAMA. 2006;296(19):2336–42.CrossRef
32.
go back to reference Fenton JJ, Zhu W, Balch S, et al. Distinguishing screening from diagnostic mammograms using medicare claims data. Med Care. 2014;52(7): e44–51.CrossRef Fenton JJ, Zhu W, Balch S, et al. Distinguishing screening from diagnostic mammograms using medicare claims data. Med Care. 2014;52(7): e44–51.CrossRef
33.
go back to reference Mittal S, Lin YL, Tan A, et al. Limited life expectancy among a subgroup of medicare beneficiaries receiving screening colonoscopies. Clin Gastroenterol Hepatol. 2014;12(3):443–450.CrossRef Mittal S, Lin YL, Tan A, et al. Limited life expectancy among a subgroup of medicare beneficiaries receiving screening colonoscopies. Clin Gastroenterol Hepatol. 2014;12(3):443–450.CrossRef
34.
go back to reference Wolf AMD, Wender RC, Etzioni RB, et al. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010. CA Cancer J Clin. 2010;60(2):70–98CrossRef Wolf AMD, Wender RC, Etzioni RB, et al. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010. CA Cancer J Clin. 2010;60(2):70–98CrossRef
35.
go back to reference Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol. 2009;104(3):739–50.CrossRef Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol. 2009;104(3):739–50.CrossRef
36.
go back to reference Schnipper LE, Lyman GH, Blayney DW, et al. American society of clinical oncology 2013 top five list in oncology. J Clin Oncol. 2013;31(34):4362–4370.CrossRef Schnipper LE, Lyman GH, Blayney DW, et al. American society of clinical oncology 2013 top five list in oncology. J Clin Oncol. 2013;31(34):4362–4370.CrossRef
37.
go back to reference Lee SJ, (2006) Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295(7):801 Lee SJ, (2006) Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295(7):801
39.
go back to reference Rauscher GH, Johnson TP, Cho YI, et al. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev. 2008;17(4):748–57.CrossRef Rauscher GH, Johnson TP, Cho YI, et al. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev. 2008;17(4):748–57.CrossRef
40.
go back to reference Chang CH, Bynum JP, Onega T, Colla CH, Lurie JD, Tosteson AN. Screening mammography use among older women before and after the 2009 U.S. Preventive Services Task Force recommendations. J Womens Health (Larchmt). 2016;25(10): 1030–1037.CrossRef Chang CH, Bynum JP, Onega T, Colla CH, Lurie JD, Tosteson AN. Screening mammography use among older women before and after the 2009 U.S. Preventive Services Task Force recommendations. J Womens Health (Larchmt). 2016;25(10): 1030–1037.CrossRef
41.
go back to reference Jemal A, Fedewa Sa, Ma J, et al. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA. 2015;314(19):2054–61.CrossRef Jemal A, Fedewa Sa, Ma J, et al. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA. 2015;314(19):2054–61.CrossRef
42.
go back to reference Rao SR, Breen N, Graubard BI. Trends in black-white disparities in breast and colorectal cancer screening rates in a changing screening environment: the peters-belson approach using united states national health interview surveys 2000-2010. Med Care. 2016;54(2):133–9.CrossRef Rao SR, Breen N, Graubard BI. Trends in black-white disparities in breast and colorectal cancer screening rates in a changing screening environment: the peters-belson approach using united states national health interview surveys 2000-2010. Med Care. 2016;54(2):133–9.CrossRef
43.
go back to reference Lee SJ, Kim CM. Individualizing prevention for older adults. J Am Geriatr Soc. 2018;66(2):229–234.CrossRef Lee SJ, Kim CM. Individualizing prevention for older adults. J Am Geriatr Soc. 2018;66(2):229–234.CrossRef
44.
go back to reference Wilt TJ, Harris RP, Qaseem A, High Value Care Task Force of the American College of Physicians. Screening for Cancer: Advice for High-Value Care From the American College of Physicians. Ann Intern Med. 2015;162(10):718–25.CrossRef Wilt TJ, Harris RP, Qaseem A, High Value Care Task Force of the American College of Physicians. Screening for Cancer: Advice for High-Value Care From the American College of Physicians. Ann Intern Med. 2015;162(10):718–25.CrossRef
45.
go back to reference Saini SD, Vijan S, Schoenfeld P, et al. Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study. BMJ. 2014;348:g1247.CrossRef Saini SD, Vijan S, Schoenfeld P, et al. Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study. BMJ. 2014;348:g1247.CrossRef
46.
go back to reference Schoenborn NL, Lee K, Pollack CE, et al. Older adults’ views and communication preferences around cancer screening cessation JAMA Intern Med. 2017;177(8):1121–1128.CrossRef Schoenborn NL, Lee K, Pollack CE, et al. Older adults’ views and communication preferences around cancer screening cessation JAMA Intern Med. 2017;177(8):1121–1128.CrossRef
Metadata
Title
Influence of Age, Health, and Function on Cancer Screening in Older Adults with Limited Life Expectancy
Authors
Nancy L. Schoenborn, MD, MHS
Jin Huang, MS
Orla C. Sheehan, MD, PhD
Jennifer L. Wolff, PhD
David L. Roth, PhD
Cynthia M. Boyd, MD, MPH
Publication date
01-01-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 1/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4717-y

Other articles of this Issue 1/2019

Journal of General Internal Medicine 1/2019 Go to the issue

Healing Arts: Materia Medica

Chronically Happy

Healing Arts: Materia Medica

Living Fully with Sickle Cell Disease

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.